These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27474233)

  • 21. Beyond antigens and adjuvants: formulating future vaccines.
    Moyer TJ; Zmolek AC; Irvine DJ
    J Clin Invest; 2016 Mar; 126(3):799-808. PubMed ID: 26928033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immunity and new adjuvants.
    Mutwiri G; Gerdts V; Lopez M; Babiuk LA
    Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
    de Veer M; Meeusen E
    Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
    Lawson LB; Norton EB; Clements JD
    Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomaterials as vaccine adjuvants.
    Jones KS
    Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunity in response to particulate antigen-delivery systems.
    Storni T; Kündig TM; Senti G; Johansen P
    Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunomodulatory properties of the vaccine adjuvant alum.
    Oleszycka E; Lavelle EC
    Curr Opin Immunol; 2014 Jun; 28():1-5. PubMed ID: 24463269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant system AS01: helping to overcome the challenges of modern vaccines.
    Didierlaurent AM; Laupèze B; Di Pasquale A; Hergli N; Collignon C; Garçon N
    Expert Rev Vaccines; 2017 Jan; 16(1):55-63. PubMed ID: 27448771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vaccine adjuvant].
    Aoshi T; Ishii KJ
    Nihon Rinsho; 2011 Sep; 69(9):1547-53. PubMed ID: 21922751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal Vaccine Development Based on Liposome Technology.
    Bernasconi V; Norling K; Bally M; Höök F; Lycke NY
    J Immunol Res; 2016; 2016():5482087. PubMed ID: 28127567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing the Next Generation of Vaccines: Relevance for Future Pandemics.
    Domínguez-Andrés J; van Crevel R; Divangahi M; Netea MG
    mBio; 2020 Dec; 11(6):. PubMed ID: 33443120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity.
    Alter G; Sekaly RP
    Vaccine; 2015 Jun; 33 Suppl 2():B55-9. PubMed ID: 26022570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine Ingredients: Components that Influence Vaccine Efficacy.
    Kocourkova A; Honegr J; Kuca K; Danova J
    Mini Rev Med Chem; 2017; 17(5):451-466. PubMed ID: 27488583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunology of vaccine adjuvants.
    Ribeiro CM; Schijns VE
    Methods Mol Biol; 2010; 626():1-14. PubMed ID: 20099117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll or toll-free adjuvant path toward the optimal vaccine development.
    Ishii KJ; Akira S
    J Clin Immunol; 2007 Jul; 27(4):363-71. PubMed ID: 17370119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current adjuvants and new perspectives in vaccine formulation.
    Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A
    Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immunity and vaccine.
    Seya T
    Vaccine; 2010 Nov; 28(50):8041-2. PubMed ID: 20849873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.